Cardiovascular implications of the COVID-19 pandemic: a global perspective
M Boukhris, A Hillani, F Moroni, MS Annabi… - Canadian Journal of …, 2020 - Elsevier
Abstract The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2), represents the pandemic of the century, with …
syndrome coronavirus-2 (SARS-CoV-2), represents the pandemic of the century, with …
COVID-19 revisiting inflammatory pathways of arthritis
Abstract Coronavirus disease 2019 (COVID-19) is an infectious disease, caused by severe
acute respiratory syndrome coronavirus 2, which predominantly affects the lungs and, under …
acute respiratory syndrome coronavirus 2, which predominantly affects the lungs and, under …
[HTML][HTML] Addressing male sexual and reproductive health in the wake of COVID-19 outbreak
Purpose The COVID-19 pandemic, caused by the SARS-CoV-2, represents an
unprecedented challenge for healthcare. COVID-19 features a state of hyperinflammation …
unprecedented challenge for healthcare. COVID-19 features a state of hyperinflammation …
Asthma-associated risk for COVID-19 development
C Skevaki, A Karsonova, A Karaulov, M Xie… - Journal of allergy and …, 2020 - Elsevier
The newly described severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is
responsible for a pandemic (coronavirus disease 2019 [COVID-19]). It is now well …
responsible for a pandemic (coronavirus disease 2019 [COVID-19]). It is now well …
Natural killer cell dysfunction and its role in COVID-19
When facing an acute viral infection, our immune systems need to function with finite
precision to enable the elimination of the pathogen, whilst protecting our bodies from …
precision to enable the elimination of the pathogen, whilst protecting our bodies from …
Human and novel coronavirus infections in children: a review
N Rajapakse, D Dixit - Paediatrics and international child health, 2021 - Taylor & Francis
Coronaviruses, seven of which are known to infect humans, can cause a spectrum of clinical
presentations ranging from asymptomatic infection to severe illness and death. Four human …
presentations ranging from asymptomatic infection to severe illness and death. Four human …
A hypothesis for pathobiology and treatment of COVID‐19: the centrality of ACE1/ACE2 imbalance
K Sriram, PA Insel - British journal of pharmacology, 2020 - Wiley Online Library
Angiotensin Converting Enzyme2 is the cell surface binding site for the coronavirus SARS‐
CoV‐2, which causes COVID‐19. We propose that an imbalance in the action of ACE1‐and …
CoV‐2, which causes COVID‐19. We propose that an imbalance in the action of ACE1‐and …
Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19
SB Solerte, A Di Sabatino, M Galli, P Fiorina - Acta diabetologica, 2020 - Springer
Aims SARS–CoV-2 causes severe respiratory syndrome (COVID-19) with high mortality due
to a direct cytotoxic viral effect and a severe systemic inflammation. We are herein …
to a direct cytotoxic viral effect and a severe systemic inflammation. We are herein …
The potential of low molecular weight heparin to mitigate cytokine storm in severe COVID‐19 patients: a retrospective cohort study
C Shi, C Wang, H Wang, C Yang, F Cai… - Clinical and …, 2020 - Wiley Online Library
On March 11, 2020, the World Health Organization declared its assessment of coronavirus
disease 2019 (COVID‐19) as a global pandemic. However, specific anti‐severe acute …
disease 2019 (COVID‐19) as a global pandemic. However, specific anti‐severe acute …
Use of tocilizumab for COVID-19-induced cytokine release syndrome: a cautionary case report
J Radbel, N Narayanan, PJ Bhatt - Chest, 2020 - Elsevier
Novel coronavirus disease 2019 (COVID-19) emerged in late December 2019 in Wuhan,
China. Since then, COVID-19 has become a pandemic affecting more than 4.1 million …
China. Since then, COVID-19 has become a pandemic affecting more than 4.1 million …